Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26713412)

  • 1. Reappraisal of hMLH1 promoter methylation and protein expression status in the serrated neoplasia pathway.
    Lee EJ; Chun SM; Kim MJ; Jang SJ; Kim do S; Lee DH; Youk EG
    Histopathology; 2016 Aug; 69(2):198-210. PubMed ID: 26713412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas.
    Hawkins NJ; Ward RL
    J Natl Cancer Inst; 2001 Sep; 93(17):1307-13. PubMed ID: 11535705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon.
    Oh K; Redston M; Odze RD
    Hum Pathol; 2005 Jan; 36(1):101-11. PubMed ID: 15712188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF V600E immunohistochemistry demonstrates that some sessile serrated lesions with adenomatous dysplasia may represent collision lesions.
    Bettington M; Liu C; Gill A; Walker N; Leggett B; Whitehall V; Rosty C
    Histopathology; 2019 Jul; 75(1):81-87. PubMed ID: 30825335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sessile serrated lesion and its borderline variant - Variables with impact on recorded data.
    Mohammadi M; Garbyal RS; Kristensen MH; Madsen PM; Nielsen HJ; Holck S
    Pathol Res Pract; 2011 Jul; 207(7):410-6. PubMed ID: 21680107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant PRDM2 methylation as an early event in serrated lesions destined to evolve into microsatellite-instable colorectal cancers.
    van Toledo DE; Bleijenberg AG; Venema A; de Wit MJ; van Eeden S; Meijer GA; Carvalho B; Dekker E; Henneman P; IJspeert JE; van Noesel CJ
    J Pathol Clin Res; 2024 Mar; 10(2):e348. PubMed ID: 38380944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agrin in the Muscularis Mucosa Serves as a Biomarker Distinguishing Hyperplastic Polyps from Sessile Serrated Lesions.
    Rickelt S; Condon C; Mana M; Whittaker C; Pfirschke C; Roper J; Patil DT; Brown I; Mattia AR; Zukerberg L; Zhao Q; Chetty R; Lauwers GY; Neyaz A; Leijssen LGJ; Boylan K; Yilmaz OH; Deshpande V; Hynes RO
    Clin Cancer Res; 2020 Mar; 26(6):1277-1287. PubMed ID: 31852835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serrated polyps of the large intestine: a molecular study comparing sessile serrated adenomas and hyperplastic polyps.
    Sandmeier D; Benhattar J; Martin P; Bouzourene H
    Histopathology; 2009 Aug; 55(2):206-13. PubMed ID: 19694828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphologic reappraisal of serrated colorectal polyps.
    Torlakovic E; Skovlund E; Snover DC; Torlakovic G; Nesland JM
    Am J Surg Pathol; 2003 Jan; 27(1):65-81. PubMed ID: 12502929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological and molecular characterization of colorectal sessile serrated lesions with dysplasia.
    Cappello F; Angerilli V; Dal Santo L; Munari G; Sabbadin M; Lo Mele M; Pennelli G; Luchini C; Parente P; Lazzi S; Fassan M
    Pathol Res Pract; 2022 Dec; 240():154214. PubMed ID: 36395596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC expression in hyperplastic and serrated colonic polyps: lack of specificity of MUC6.
    Gibson JA; Hahn HP; Shahsafaei A; Odze RD
    Am J Surg Pathol; 2011 May; 35(5):742-9. PubMed ID: 21490447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperplastic polyps of the colon and rectum - reclassification, BRAF and KRAS status in index polyps and subsequent colorectal carcinoma.
    Janjua HG; H√łgdall E; Linnemann D
    APMIS; 2015 Apr; 123(4):298-304. PubMed ID: 25708741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of expression of MLH1 in non-dysplastic crypts is a harbinger of neoplastic progression in sessile serrated adenomas/polyps.
    Yozu M; Kem M; Cenaj O; Mino-Kenudson M; Odze RD; Misdraji J
    Histopathology; 2019 Sep; 75(3):376-384. PubMed ID: 30974487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive methylation during the serrated neoplasia pathway of the colorectum.
    Dong SM; Lee EJ; Jeon ES; Park CK; Kim KM
    Mod Pathol; 2005 Feb; 18(2):170-8. PubMed ID: 15389252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation changes that precede onset of dysplasia in advanced sessile serrated adenomas.
    Liu C; Fennell LJ; Bettington ML; Walker NI; Dwine J; Leggett BA; Whitehall VLJ
    Clin Epigenetics; 2019 Jun; 11(1):90. PubMed ID: 31200767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on the morphology and molecular pathology of serrated colorectal polyps and associated carcinomas.
    Pai RK; Bettington M; Srivastava A; Rosty C
    Mod Pathol; 2019 Oct; 32(10):1390-1415. PubMed ID: 31028362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unmasking early colorectal cancer clues: in silico and in vitro investigation of downregulated IGF2, SOCS1, MLH1, and CACNA1G in SSA polyps.
    Mirbahari SN; Fatemi N; Savabkar S; Chaleshi V; Zali N; Taleghani MY; Mirzaei E; Rejali L; Moghadam PK; Mojarad EN
    Mol Biol Rep; 2024 Jun; 51(1):764. PubMed ID: 38874740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sessile serrated lesions: Clinicopathological characteristics, endoscopic diagnosis, and management.
    Murakami T; Kurosawa T; Fukushima H; Shibuya T; Yao T; Nagahara A
    Dig Endosc; 2022 Sep; 34(6):1096-1109. PubMed ID: 35352394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign serrated colorectal fibroblastic polyps/intramucosal perineuriomas are true mixed epithelial-stromal polyps (hybrid hyperplastic polyp/mucosal perineurioma) with frequent BRAF mutations.
    Agaimy A; Stoehr R; Vieth M; Hartmann A
    Am J Surg Pathol; 2010 Nov; 34(11):1663-71. PubMed ID: 20962618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
    O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
    Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.